US 7517527
Immunotoxin with in vivo T cell suppressant activity and methods of use
granted A61KA61K2039/505A61K47/6829
Quick answer
US patent 7517527 (Immunotoxin with in vivo T cell suppressant activity and methods of use) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Apr 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2039/505, A61K47/6829, A61K47/6849